APOE is a well-studied gene involved in lipid metabolism. The ε4 variant is associated with increased risk for Alzheimer's disease and cardiovascular disease, which can reduce lifespan. However, APOE ε4 is not a 'longevity gene' in a positive sense – there is no evidence that carriers live longer. Many direct-to-consumer tests market APOE as part of a 'longevity panel', but the effects are complex and heavily modulated by lifestyle, environment, and other genes. A positive ε4 result can cause psychological distress without offering proven preventive measures. The evidence for the Alzheimer's link is human-strong, but for overall longevity it is moderate and not causal. Consumers should understand that a genetic test does not provide a prognosis, and that healthy diet, exercise, and cognitive engagement matter far more than the APOE variant. Beware of exaggerated marketing claims.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-1a0fc38181da0c2ed070082b